GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,440 | -7,120 | -5,150 | -5,990 | -8,890 |
| Depreciation Amortization | 830 | 1,550 | 1,220 | 1,380 | 1,360 |
| Other Working Capital | 360 | -250 | N/A | N/A | N/A |
| Other Operating Activity | 780 | 580 | -910 | 340 | 2,280 |
| Operating Cash Flow | $-2,470 | $-5,240 | $-4,840 | $-4,270 | $-5,250 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1,710 | -100 | N/A | N/A | N/A |
| Other Investing Activity | 440 | -140 | -110 | -400 | 400 |
| Investing Cash Flow | $2,150 | $-240 | $-110 | $-400 | $400 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -1,470 | 6,830 | 5,900 | 4,380 | 4,630 |
| Financing Cash Flow | $-1,470 | $6,830 | $5,900 | $4,380 | $4,630 |
| Exchange Rate Effect | 20 | -60 | -70 | -3 | 6 |
| Beginning Cash Position | 2,570 | 1,290 | 420 | 720 | 930 |
| End Cash Position | 780 | 2,570 | 1,290 | 420 | 720 |
| Net Cash Flow | $-1,780 | $1,280 | $860 | $-300 | $-200 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,470 | -5,240 | -4,840 | -4,270 | -5,250 |
| Free Cash Flow | -2,470 | -5,240 | -4,840 | -4,270 | -5,250 |